Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02407028 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric Oxygen Brain Injury Treatment Trial
A Phase 2 study of Traumatic Brain Injury, sponsored by Gaylan Rockswold.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 11
- Study locations
NCT02407028: Recruiting Phase 2 study of Traumatic Brain Injury, sponsored by Gaylan Rockswold.
NCT02407028 is a Phase 2 study of Traumatic Brain Injury that is actively recruiting participants, run by Gaylan Rockswold. The registered enrollment target is 200 participants, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (28% lower). The trial reports 11 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02407028, a Phase 2 study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Gaylan Rockswold.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate improvement in the outcome of severe TBI patients in a subsequent phase III trial.
Conditions Studied
Interventions
- DRUG Hyperbaric oxygen (1.5 ATA, no NBH)
- DRUG Hyperbaric oxygen (2.0 ATA, no NBH)
- DRUG Hyperbaric oxygen (2.5 ATA, no NBH)
- DRUG Hyperbaric oxygen (1.5 ATA + NBH)
- DRUG Hyperbaric oxygen (2.0 ATA + NBH)
Study Locations (11)
California
- UCSD Medical Center - Hillcrest Hospital - San Diego
Florida
- St. Mary's Medical Center - West Palm Beach
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Kentucky
- University of Kentucky Hospital - Lexington
Maryland
- University of Maryland - Baltimore
Michigan
- Detroit Receiving Hospital - Detroit
Minnesota
- Hennepin County Hospital - Minneapolis
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2029-06-30 |
| Phase | Phase 2 |
What NCT02407028 shows while recruiting
NCT02407028 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 5 interventions - of which Hyperbaric oxygen (1.5 ATA, no NBH) is the first listed.
NCT02407028 lists 11 locations in 11 states (California, Florida, Iowa).
Frequently Asked Questions
What is clinical trial NCT02407028 about?
NCT02407028 is a clinical study titled "Hyperbaric Oxygen Brain Injury Treatment Trial". The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate improvement in the outcome of severe TBI patients in a subsequent phase III trial.
What is the current status of trial NCT02407028?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2018-06-25. Estimated completion is 2029-06-30.
What conditions does trial NCT02407028 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT02407028?
The interventions under investigation include: Hyperbaric oxygen (1.5 ATA, no NBH) (DRUG), Hyperbaric oxygen (2.0 ATA, no NBH) (DRUG), Hyperbaric oxygen (2.5 ATA, no NBH) (DRUG), Hyperbaric oxygen (1.5 ATA + NBH) (DRUG), Hyperbaric oxygen (2.0 ATA + NBH) (DRUG).
Who is sponsoring clinical trial NCT02407028?
This trial is sponsored by Gaylan Rockswold, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02407028 being conducted?
This trial has 11 study locations across California, Florida, Iowa, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02407028's enrollment target sits among peer trials
200 33rd of 171 higher than 137 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)
RECRUITING · Phase 2
-
Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)
RECRUITING · Phase 2
-
High Intensity Step Training After Traumatic Brain Injury
RECRUITING · Phase 2
-
Sildenafil for Microvasculopathy in Chronic TBI
RECRUITING · Phase 2
-
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
RECRUITING · Phase 2
-
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI